Past Conferences

The ADDF’s scientific conferences promote the exchange of ideas, the sharing of research results, and the formation of strategic alliances to further drug development goals. For more information about an upcoming conference, please contact Sara Classen at 212-901-8009 or sclassen@alzdiscovery.org.

To stay informed of ADDF scientific conferences please take a moment to add or reconfirm your participation in our mailing list.

Sort conferences

Event: 8th Annual Drug Discovery for Neurodegeneration Conference

Date: February 2-4, 2014

Location: Miami, FL

Description:

The 8th Annual Drug Discovery for Neurodegeneration Conference is designed as a comprehensive course on the drug discovery process, from target validation through to clinical development, the annual Drug Discovery for Neurodegeneration conference provides participants with the fundamental knowledge and resources to translate their research into new drugs to treat and prevent Alzheimer's disease and related neurodegenerative diseases.

Attendees from academia and industry will also learn from specific case studies examples and will have an opportunity to engage in interactive discussions on securing partnerships.

The program will include a focus on Alzheimer’s disease, Parkinson’s disease and Multiple Sclerosis.

 

More information, please visit our Conference Website.

 

Event: ADDF to Exhibit at the Society for Neuroscience Annual Meeting

Date: November 9-13, 2013

Location: San Diego, CA

Description:

Come visit the ADDF team at booth number 4004. Learn more about our upcoming conferences, grant opportunities, our newly launched ADDF ACCESS program and much more!

Event: 14th International Conference on Alzheimer’s Drug Discovery

Date: September 8-10, 2013

Location: Jersey City, NJ

Description:

This annual conference brings together academic and industry scientists intent on accelerating the development of innovative treatments for Alzheimer’s disease and related dementias. The ADDF’s funded investigators and top-level scientists in the field will present on their current research progress and stimulate discussion. The conference offers ample opportunity for collaboration and partnering

 

For more information, please visit our Conference Website.

Event: Translating Natural Products into Drugs for Alzheimer’s and Neurodegenerative Disease

Date: May 6, 2013

Location: New York City, NY

Description:

Historically, natural products have been a highly successful source for the development of new drugs. Alzheimer's and other neurodegenerative diseases are fraught with challenging drug targets that may benefit from the novel chemistries present in natural products. In addition, technological advances may present new opportunities for drug discovery based on natural product leads. This conference will present an overview of drug discovery from natural products, including novel approaches and technologies, and promising Alzheimer's drug discovery programs that originated from natural products. To view the ebriefing.

Event: 7th Annual Drug Discovery for Neurodegeneration Conference

Date: February 10-12, 2013

Location: San Francisco, CA

Description:

The 7th Annual Drug Discovery for Neurodegeneration Conference course is designed to advance the development of new drugs for neurodegenerative diseases by educating scientists on the principles and practice of drug discovery, including topics such as high throughput screening, lead optimization, preclinical proof-of-concept, and IND enabling and regulator issues. The program will focus on Alzheimer’s disease, Parkinson’s disease, Amyotrophic Lateral Sclerosis and Multiple Sclerosis.

 

For more information, please visit our Conference Website.

Event: ADDF to Exhibit at the Society for Neuroscience Annual Meeting

Date: October 13-17, 2012

Location: New Orleans, LA

Description:

Event: 13th International Conference on Alzheimer’s Drug Discovery

Date: September 10-11, 2012

Location: Jersey City, NJ

Description:

This annual conference brings together academic and industry scientists intent on accelerating the development of innovative treatments for Alzheimer’s disease and related dementias. The ADDF’s funded investigators and top-level scientists in the field will present on their current research progress and stimulate discussion. The conference offers ample opportunity for collaboration and partnering. 

 

For more information, please visit our Conference Website

Event: Targeting Synaptic Dysfunction in Alzheimer’s Disease

Date: May 18, 2011

Location: New York, NY

Description:

Optimal functioning of neural networks is critical to the complex cognitive processes of memory, language, emotion, and reasoning that deteriorate in Alzheimer's disease. Understanding the mechanisms by which synaptic connections are formed and create neural networks is crucial to developing new drugs to protect and maintain neuronal function and connectivity. This conference provided an overview of the process of synaptic plasticity in normal aging and in neurodegenerative disease, and outline therapeutic strategies to preserve vital neural connections.

 

Learn More

Event: Targeting Synaptic Dysfunction in Alzheimer’s Disease

Date: May 18, 2012

Location: New York City, NY

Description:

For more information, please visit our Conference Website

Event: Targeting the Vasculature in Alzheimer’s Disease and Vascular Cognitive Impairment

Date: May 6, 2012

Location: New York City, NY

Description:

For more information, please visit our Conference Website

Event: 6th Drug Discovery for Neurodegeneration: An Intensive Course on Translating Research into Drugs

Date: February 12-14, 2012

Location: New York City, NY

Description:

The 6th Annual Drug Discovery for Neurodegeneration Conference course is designed to advance the development of new drugs for neurodegenerative diseases by educating scientists on the principles and practice of drug discovery, including topics such as high throughput screening, lead optimization, preclinical proof-of-concept, and IND enabling and regulator issues. The program will focus on Alzheimer’s disease, Parkinson’s disease, Amyotrophic Lateral Sclerosis and Multiple Sclerosis.

 

For more information, please visit our Conference Website

Event: 12th International Conference on Alzheimer’s Drug Discovery

Date: September 26-27, 2011

Location: Jersey City, NJ

Description:

This global conference was designed to accelerate the development of innovative treatments for Alzheimer’s disease (AD), related dementias and cognitive aging. The ADDF’s funded investigators and top level scientists in the field presented on their current research progress and stimulated discussion.  The conference provided ample opportunity for scientists to network, form collaborations, and share information and resources. The meeting attracted 135 key stakeholders from the pharmaceutical, biotechnology, government and academic communities.

 

For more information, please visit our Conference Website

Event: 5th Drug Discovery for Neurodegeneration: An Intensive Course on Translating Research into Drugs

Date: February 6-8, 2011

Location: San Diego, CA

Description:

Designed as a comprehensive course, this annual conference provided participants with the fundamental knowledge and resources, as well as the associated barriers, and challenges on creating new drugs to treat and prevent neurodegenerative disease. Case studies on Alzheimer’s disease, Parkinson’s disease, Huntington’s disease, Amyotrophic Lateral Sclerosis, and Multiple Sclerosis were included in the discussions.  The meeting attracted 142 academic, industry, and government scientists from around the world. The ADDF developed this conference in collaboration with the National Institutes of Health (NIH).

 

Click here to view a webcasts of the conference proceedings.  There is also an interactive Drug Discovery Tutorial based of the conference, which can be accessed here.

 

For more information, please visit our Conference Website

Event: International Pharmaco-Economic Conference on Alzheimer’s Disease

Date: February 3-4, 2011

Location: London, UK

Description:

The ADDF co-developed and organized the 6th International Conference on Pharmacoeconomics on Alzheimer’s Disease (IPECAD) meeting with the Karolinska Institutet, Stockholm. IPECAD is the only conference that exclusively addresses issues related to the economic evaluation of drug treatments for Alzheimer’s disease. It brings together leading experts and opinion leaders from academia, regulatory bodies and the pharmaceutical industry. Approximately 75 health economists and scientists from around the world attended this meeting. 

 

For more information, please visit our Conference Website

Event: Feeding the Pipeline: Novel Targets for Alzheimer’s Drug Discovery

Date: November 3, 2010

Location: Toulouse, France

Description:

This one-day symposium focused on European biotechnology companies conducting early-stage high risk research for Alzheimer’s disease that complement approaches in advanced clinical trials. This satellite meeting was held in conjunction with the 3rd Clinical Trials for Alzheimer’s Disease (CTAD) conference. The symposium attracted approximately 250 attendees from all over the world and all levels of academia, government, and industry.

 

For more information, please visit our Conference Website

Event: 11th Annual International Conference on Alzheimer’s Drug Discovery

Date: September 27-28, 2010

Location: Jersey City, NJ

Description:

This global conference was designed to help accelerate the development of innovative treatments for Alzheimer’s disease, related dementias, and cognitive aging. The ADDF’s funded investigators and top level scientists in the field presented on their current research progress and stimulated discussion. The conference provided ample opportunity for scientists to network, form collaborations, and share information and resources. The meeting attracted 155 key stakeholders from the pharmaceutical, biotechnology, government and academic communities.

 

For more information, please visit our Conference Website

Event: Mitochondrial Function as a Therapeutic Target for Alzheimer’s Disease

Date: May 13, 2010

Location: New York City, NY

Description:

Growing evidence indicates that mitochondrial dysfunction is one of the key intracellular mechanisms associated with the pathogenesis of Alzheimer's disease. The role of mitochondria as regulators of energy metabolism and cell death pathways makes it crucial to neuronal cell survival or death. The goal of this conference was to critically examine potential drug therapeutics for mitochondrial dysfunction in Alzheimer’s disease. Recent findings from basic, clinical, and translational research were presented in a forum designed to stimulate discussion of mitochondrial function and its relationship to age-related neurodegenerative disease, in particular, Alzheimer’s disease and its treatment.

 

For more information, please visit our Conference Website

Event: 4th Drug Discovery for Neurodegeneration: An Intensive Course on Translating Research into Drugs

Date: February 1-2, 2010

Location: Houston, TX

Description:

Designed as a comprehensive course, this annual conference provided participants with the fundamental knowledge and resources, as well as the associated barriers and challenges on creating new drugs to treat and prevent neurodegenerative disease. Case studies on Alzheimer’s disease, Parkinson’s disease, Amyotrophic Lateral Sclerosis and Multiple Sclerosis were included in the discussions. The meeting attracted 92 leading academic, industry and government scientists from around the world. The ADDF developed this conference in collaboration with the National Institutes of Health (NIH). Click here to view a webcast of the conference proceedings. 

 

For more information, please visit our Conference Website

Event: 9th International Conference on Alzheimer’s Disease Drug Discovery

Date: October 6-7, 2008

Location: New York, NY

Description:

This global conference was designed to help accelerate the development of innovative treatments for Alzheimer’s disease, related dementias, and cognitive aging. The ADDF’s funded investigators and top level scientists in the field presented on their current research progress and stimulated discussion. The conference provided ample opportunity for scientists to network, form collaborations, and share information and resources. The meeting attracted 156 key stakeholders from the pharmaceutical, biotechnology, government and academic communities.

 

For more information, please visit our Conference Website

Event: 10th International Conference on Alzheimer’s Drug Discovery

Date: September 14-15, 2009

Location: Jersey City, NJ

Description:

This global conference was designed to help accelerate the development of innovative treatments for Alzheimer’s disease, related dementias, and cognitive aging. The ADDF’s funded investigators and top level scientists in the field presented on their current research progress and stimulated discussion. The conference provided ample opportunity for scientists to network, form collaborations, and share information and resources. The meeting attracted 113 key stakeholders from the pharmaceutical, biotechnology, government and academic communities.

 

For more information, please visit our Conference Website

Event: Therapeutics for Cognitive Aging

Date: May 15, 2009

Location: New York City, NY

Description:

This one day symposium focused on an issue of great importance to an aging society – the development of novel therapies for cognitive decline across the lifespan of humans. This meeting convened prominent basic and clinical scientists who study the cognitive and neurobiological aspects of aging and its consequences for cognition. Speakers covered three main areas: the definition of cognitive aging, the underlying neurobiology of cognitive aging, and issues in the development of potential new therapies for cognitive aging including the use of biomarkers, drug therapy and a discussion of related regulatory issues.

 

For more information, please visit our Conference Website

Event: 3rd Drug Discovery for Neurodegeneration: An Intensive Course on Translating Research into Drugs

Date: February 2-3, 2009

Location: Washington, DC

Description:

Designed as a comprehensive course, this annual conference provided participants with the fundamental knowledge and resources, as well as the associated barriers and challenges on creating new drugs to treat and prevent neurodegenerative disease. Case studies on Alzheimer’s disease, Parkinson’s disease, Amyotrophic Lateral Sclerosis, Huntington’s disease and Multiple Sclerosis were included in the discussions. The meeting attracted 140 leading academic, industry and government scientists from around the world. The ADDF developed this conference in collaboration with the National Institutes of Health (NIH). 

 

For more information, please visit our Conference Website

Event: 2nd Drug Discovery for Neurodegeneration: An Intensive Course on Translating Research into Drugs

Date: February 4-5, 2008

Location: Washington, DC

Description:

Designed as a comprehensive course, this annual conference provided participants with the fundamental knowledge and resources, as well as the associated barriers and challenges on creating new drugs to treat and prevent neurodegenerative disease. Case studies on Alzheimer’s disease, Parkinson’s disease, Amyotrophic Lateral Sclerosis, Huntington’s disease, and Multiple Sclerosis were included in the discussions. The meeting attracted 155 leading academic, industry and government scientists from around the world. The ADDF developed this conference in collaboration with the National Institutes of Health (NIH). 

 

For more information, please visit our Conference Website

Event: 8th International Conference on Alzheimer’s Disease Drug Discovery

Date: October 15-16, 2007

Location: New York, NY

Description:

This global conference was designed to help accelerate the development of innovative treatments for Alzheimer’s disease, related dementias and cognitive aging. The ADDF’s funded investigators and top level scientists in the field presented on their current research progress and stimulated discussion. The conference provided ample opportunity for scientists to network, form collaborations, and share information and resources. The meeting attracted 139 key stakeholders from the pharmaceutical, biotechnology, government and academic communities.

 

For more information, please visit our Conference Website

Event: 1st Drug Discovery for Neurodegeneration: An Intensive Course on Translating Research into Drugs

Date: February 5-6, 2007

Location: New York, NY

Description:

Designed as a comprehensive course, this annual conference provided participants with the fundamental knowledge and resources, as well as the associated barriers and challenges on creating new drugs to treat and prevent neurodegenerative disease. The meeting attracted approximately 135 leading academic, industry and government scientists from around the world. The ADDF developed this conference in collaboration with the National Institutes of Health (NIH).

 

For more information, please visit our Conference Website